» Articles » PMID: 38548737

Microevolution, Reinfection and Highly Complex Genomic Diversity in Patients with Sequential Isolates of Mycobacterium Abscessus

Abstract

Mycobacterium abscessus is an opportunistic, extensively drug-resistant non-tuberculous mycobacterium. Few genomic studies consider its diversity in persistent infections. Our aim was to characterize microevolution/reinfection events in persistent infections. Fifty-three sequential isolates from 14 patients were sequenced to determine SNV-based distances, assign resistance mutations and characterize plasmids. Genomic analysis revealed 12 persistent cases (0-13 differential SNVs), one reinfection (15,956 SNVs) and one very complex case (23 sequential isolates over 192 months), in which a first period of persistence (58 months) involving the same genotype 1 was followed by identification of a genotype 2 (76 SNVs) in 6 additional alternating isolates; additionally, ten transient genotypes (88-243 SNVs) were found. A macrolide resistance mutation was identified from the second isolate. Despite high diversity, the genotypes shared a common phylogenetic ancestor and some coexisted in the same specimens. Genomic analysis is required to access the true intra-patient complexity behind persistent infections involving M. abscessus.

Citing Articles

Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person Transmission.

Olawoye I, Waglechner N, McIntosh F, Akochy P, Cloutier N, Grandjean Lapierre S J Infect Dis. 2024; 231(2):e396-e406.

PMID: 39189818 PMC: 11841644. DOI: 10.1093/infdis/jiae407.

References
1.
Gutierrez A, Baron S, Sardi F, Saad J, Coltey B, Reynaud-Gaubert M . Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients. J Cyst Fibros. 2021; 20(3):421-423. DOI: 10.1016/j.jcf.2021.02.002. View

2.
Bryant J, Grogono D, Greaves D, Foweraker J, Roddick I, Inns T . Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013; 381(9877):1551-60. PMC: 3664974. DOI: 10.1016/S0140-6736(13)60632-7. View

3.
Lewin A, Kamal E, Semmler T, Winter K, Kaiser S, Schafer H . Genetic diversification of persistent within cystic fibrosis patients. Virulence. 2021; 12(1):2415-2429. PMC: 8526041. DOI: 10.1080/21505594.2021.1959808. View

4.
Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G . Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. Am J Respir Crit Care Med. 2018; 198(9):1177-1187. PMC: 6221579. DOI: 10.1164/rccm.201802-0215OC. View

5.
Cardoso R, Martin-Blecua I, Baldin V, Meneguello J, Valverde J, Blazquez J . Noncanonical Mismatch Repair Protein NucS Modulates the Emergence of Antibiotic Resistance in Mycobacterium abscessus. Microbiol Spectr. 2022; 10(6):e0222822. PMC: 9769700. DOI: 10.1128/spectrum.02228-22. View